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Abstract
Background: The present study has investigated the protein tyrosine phosphatase H1 (PTPH1)
expression pattern in mouse brain and its impact on CNS functions.
Methods: We have previously described a PTPH1-KO mouse, generated by replacing the PTP
catalytic and the PDZ domain with a LacZ neomycin cassette. PTPH1 expression pattern was
evaluated by LacZ staining in the brain and PTPH1-KO and WT mice (n = 10 per gender per
genotype) were also behaviorally tested for CNS functions.
Results: In CNS, PTPH1 is expressed during development and in adulthood and mainly localized
in hippocampus, thalamus, cortex and cerebellum neurons. The behavioral tests performed on the
PTPH1-KO mice showed an impact on working memory in male mice and an impaired learning
performance at rotarod in females.
Conclusion: These results demonstrate for the first time a neuronal expression of PTPH1 and its
functionality at the level of cognition.
Background
Tyrosine phosphorylation plays an important role in sev-
eral signaling pathways regulating cell growth, differenti-
ation, cell cycle, apoptosis and neuronal functions [1,2].
The phosphorylation/dephosphorylation balance is con-
trolled by protein tyrosine kinases and phosphatases.
PTPs can be distinguished into four classes: 1) classical
PTPs that can be subdivided into transmembrane, recep-
tor-like enzymes, and the intracellular, nonreceptor PTPs,
2) dual-specificity PTPs (Ser and Tyr phosphatases), 3)
low molecular weight PTP and 4) the Asp-based PTPs
(Tyr/Ser phosphatase activity) [3].
Classical PTPs have been reported to play a key role in
neural functions, from development to cognitive func-
tion. For example, RPTPs such as PTPδ, PTPσ, LAR, and
especially PTPRO, are important players in axonal growth
and guidance during development [4]. Studies on PTPσ-
KO (RPTP) mice have shown involvement of this PTP in
the regulation of the developing hypothalamo-pituitary
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axis [5,6] and in the development of the CNS architecture
[7]. PTPBL-KO (non receptor like PTP-NRPTP) mice dis-
play impaired motor nerve repair in a model of sciatic
nerve crush lesion [8] and PTPMEG (NRPTP) interacts
with key intracellular players leading to the stimulation of
the channel activity of NMDA receptors [9].
In the present study we focused our attention on a NRPTP,
PTPH1, and on its possible role on neural functions.
Indeed PTPH1 has been shown to be expressed in the CNS
[10] but little is currently known on its potential impact
on CNS functions. PTPH1 (also called PTPN3) belongs to
a sub-family of non receptor cytosolic PTPs characterized
by the presence of a FERM domain (band 4.1, ezrin,
radixin, moesin) at its N-terminus, responsible for the
interaction with transmembrane proteins and/or phos-
pholipids in the cell membrane [11-13]. In addition
PTPH1 has a PDZ domain in the central part responsible
for the interaction with other proteins, whereas the single
catalytic domain is located at the C-terminus.
PTPH1 activity has been involved in a variety of cellular
functions including TCR-signaling [14-16], cell cycle reg-
ulation [11,16,17], endoplasmic reticulum assembly [18],
cardiac sodium channel modulation [19] and TNFα con-
verting enzyme inhibition [20].
Recently, our group has demonstrated that PTPH1
dephosphorylates GHR in vitro and in cellular assays [21]
and results in an increase of body weight in the functional
PTPH1-knockout (KO) mice via modulation of IGF1
secretion [22] thus demonstrating its in vivo relevance.
PTPH1 has been shown in the rat to be highly expressed
in thalamic nuclei as well as various cortical areas [10].
However, no information is currently available on its
impact on CNS functions. To address this question we
have further characterized our PTPH1-KO mice line
through behavioral and anatomical approaches. PTPH1
expression and localization was evaluated by LacZ stain-
ing in the brain and a behavioral test battery evaluated
PTPH1 loss on CNS functions such as locomotor activity
(open field), anxiety-like behavior (open field and ele-
vated plus maze), motor ability, coordination and learn-
ing (accelerating rotarod), spatial working memory (Y
maze) and nociceptive sensitivity (hot plate).
Methods
Animals
PTPH1-KO and wild type littermates (F2 generation,
87.5% C57Bl/6 – 12.5% 129S6SvEv) aged 3–4 months
were used for behavioral phenotyping. Mice were individ-
ually caged and maintained in a 12:12 hours light: dark
cycle (lights on at 7 am) at 21 ± 1°C with food and water
available ad libitum. Protection of animals used in the
experiment was in accordance with Directive 86/609/EEC,
enforced by the Italian D.L. No. 116 of January 27, 1992.
Physical facilities and equipment for accommodation and
care of animals were in accordance with the provisions of
EEC Council Directive 86/609. Tail snips from mice were
collected and genotyped as previously reported [22].
PTPH1 KO design
PTPH1-KO mice were generated using the Velocigene
technology [23], as described in details elsewhere [22].
Briefly a mouse BAC containing the PTPH1 gene was
modified: an in-frame LacZ reporter sequence and a neo-
mycin-selectable marker replaced exons 15 to 22 encod-
ing for the PDZ and the catalytic domain of PTPH1. BAC
electroporation into embryonic stem cells was performed.
F1 heterozygous mice were bred to generate F2 PTPH1-KO
mice. Line breeding and animal care were performed in
Charles River Italy and France.
LacZ staining procedure and immunohistochemistry
PTPH1-KO and WT mice, 12 months old, n = 2, male and
females, were sacrificed by ip overdose of thiopental
(5%), perfused with paraformaldehyde 4%, then washed
in PBS and incubated overnight at 37°C in the solution
containing the substrate for beta-galactosidase (beta-gal,
encoded by the LacZ cassette) coupled to a NBT salt. The
organs and the tissues in the sections display a green/blue
staining where PTPH1 gene is normally expressed. After
rinsing into PBS, organs were postfixed in PFA 4% for 1
hour, then incubated in 50% glycerol overnight at 4°C
and finally maintained in 70% glycerol at room tempera-
ture. LacZ staining was observed through a low magnifica-
tion microscope and described by an operator blind to the
genotypes.
LacZ staining was also performed on CNS sections. Mice
(n = 3, 12 months old) were sacrificed by ip injection of
an overdose of thiopental (5%), perfused with PBS and
PFA 4%. Brains were removed and postfixed overnight at
4°C in PFA 4%, then placed overnight at 4°C in 15% and
finally in 30% sucrose buffer. The brains were then
included in O.C.T. (Tissue-Tek) and sections were cut on
slides with a cryostat at 20 μm thickness. The slides were
incubated in LacZ staining solution (see above) overnight
at 37°C, washed thrice in PBS (5 min each) and either
counterstained with H&E (Merck KGaA) [23] or co-
expressed with NeuN immunostaining. Briefly, sections
were incubated for 3 hours at room temperature in block-
ing solution (Vectastain Kit), washed in TBS (Tris-buffered
saline), incubated overnight at 4°C with a solution con-
taining the primary antibody mouse anti-mouse Neuro-
nal Nuclei (Chemicon MAB377, 1/1000). The staining
was revealed by ABC kit secondary antibody (mouse
Vectastain Kit), and DAB (Sigma). After dehydration, sec-
tions were transferred onto coverslips. LacZ staining andBehavioral and Brain Functions 2008, 4:36 http://www.behavioralandbrainfunctions.com/content/4/1/36
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co-expression with NeuN-immunoreactivity (NeuN-ir)
was observed by microscopy and described by an operator
blind to the genotypes.
Semiquantitative RT-PCR for beta galactosidase gene
Semiquantitative RT-PCR for PTPH1 and beta-gal gene
expression was performed in different brain areas of
PTPH1-KO and WT mice in order to confirm the presence
of beta-gal expression in the KO tissues, replacing PTPH1
PDZ and catalytic domain. Brains from KO and WT mice
(n = 5, 6 months old) were freshly removed and rinsed in
HBSS. Hippocampus, cerebellum, cortex, striatum, mid-
brain and olfactory bulbs were dissected. Total RNA was
extracted using Trizol Reagent (Invitrogen) and cleaned-
up by RNAeasy columns from Qiagen. 5 μg of total RNA
were used to perform the RT-PCR reaction (SuperScript II
RT kit, Invitrogen). The primer sequences for LacZ ampli-
fication were the following: LacZ – forward 5'-GAT GTA
CGT GCC CTG GAA CT/reverse 5'-GGT CCC ACA CTT
CAG CAT TT. In order to load equally the reaction mixes,
a 300 bp fragment of Histone 2A was amplified as a house
keeping gene with the following primers: H2Az forward –
5' CGT ATT CAT CGA CAC CTG AAA; H2Az reverse – 5'
CTG TTG TCC TTT CTT CCC GAT.
Behavioral phenotyping test battery
Neurological functions of PTPH1-WT and KO mice
(males and females, 11 weeks-old, n = 10 per gender per
genotype) were assessed through a behavioral test battery.
The sequence of the test battery was chosen from the least
invasive to the most ones. The schedule of the testing ses-
sions included one week of recovery from one test to the
next, as reported in Table 1.
Open field
After one hour of adaptation in the testing room, each
mouse was placed in an open field chamber (50 cm2 wide
with white floor and walls) (ViewPoint Life Sci. Inc.) to
test locomotor activity and anxiety-like behaviors. Loco-
motion was recorded for one hour by a video camera and
analyzed automatically by VideoTRACK® software (View-
Point Life Sci. Inc.). Locomotor activity was evaluated by
calculating the total path length traveled, whereas the rel-
ative time spent in the center was taken as indicative of
anxiety-like behavior [24]. The tests were performed in
two sessions with equivalent group representation.
Elevated plus maze
After one hour of adaptation in the testing room, anxiety-
like behavior was tested for each mouse by EPM within
one session. The apparatus consists of four arms (29.5 cm
long and 5 cm wide each). Two arms are open whereas the
2 others are limited by 2 black walls (20 cm high). The
number of entries of each mouse in the open and closed
arms was recorded by a video camera during a period of 5
minutes and analyzed by the SMART Video-Tracking Soft-
ware (ViewPoint Life Sci. Inc.). The total number of
entries into the arms is an index of locomotion, whereas
the percentage of time spent and percentage of entries in
the closed arms is an index of anxiety-like behaviors [25].
Accelerated rotarod
Motor ability, coordination and learning were evaluated
by using an Accelerated Rotarod apparatus for mice (Cat.
# 7650 by Jones and Roberts, distr. by Basile Instr., Italy).
The apparatus was placed within the animal colony room
and was cleaned after each trial. Mice were tested for their
abilities to maintain a balance on a rotating bar, which
accelerated from 4 to 40 rpm/min in a 5 min trial. Latency
to fall off was measured within one session and all mice
underwent four trials (one every 30 min) [26-28]. The dif-
ferences at the rotarod performances in WT and KO were
assessed by a single set of trials [27,28]. This set-up allows
a major focus on the early phases of motor learning,
involving a strong activation of prefrontal cortex and of
the associative areas of basal ganglia and cerebellum
[29,30].
Y-maze alternation
After one hour of adaptation in the testing room, mice
were tested on a Y maze apparatus (40 cm long/8 cm wide
arms with transparent walls) to investigate spatial work-
ing memory [31]. The number and the sequence of the
arm entries for each mouse were recorded during 5 min-
utes. The locomotion index was calculated as the overall
number of arm entries, whereas the working memory
index was calculated as following: number of exact alter-
nations (entries into three different arms consecutively)/
possible alternations (i.e. the number of arms entered
minus 2) × 100.
Hot plate
Thermal sensitivity was assessed by a hot plate apparatus
for mice (Cat. # 7280 by Biol. Research Apparatus, distr.
by Basile Instr., Italy) and lasted a maximum of 45 sec-
onds, time at which damages could occur [32]. The appa-
Table 1: Schedule of the behavioral test battery.
Age (wks) 8 9 10 11 12 13 14 15
10M+10F arrival quarantine adaptation Open Field EPM Rotarod Y-maze Hot plateBehavioral and Brain Functions 2008, 4:36 http://www.behavioralandbrainfunctions.com/content/4/1/36
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ratus was placed in the animal colony room and all the
mice were tested within one session. Animals were placed
on a surface heated at 52.5°C and the latency (seconds) to
shake or lick the paw was recorded by the operator.
Statistics
Statistical comparisons were performed by unpaired two-
tailed T-test (p < 0.05) and two-way ANOVA (p < 0.05)
followed by post-hoc test as necessary. In the accelerated
rotarod, two-way ANOVA with repeated measures fol-
lowed by T-test was used. Results are expressed as mean ±
SEM.
Results
LacZ staining in whole mount
In PTPH1-KO adult animals, LacZ staining in the brain
was observed in the cerebellum, hippocampus and in the
thalamic nuclei. In addition a strong staining was
observed in the cerebral cortex, tenia tecta and septum
(Figures 1a, 1b).
LacZ staining in sections and RT-PCR results
No gross cytoarchitectural brain differences were observed
by simple visual observation at the microscope in the cor-
tex, hippocampus and thalamus in PTPH1-KO mice com-
pared to WT littermates.
LacZ staining was performed on frozen brain sections to
confirm and to describe the expression of PTPH1 at the
brain structural level (Table 2).
In cortical regions, LacZ was expressed in the external
pyramidal (III) and internal granular layer (IVA) of the
cerebral cortex (Figures 2a, 2b), in the retrosplenial cortex
(Figures. 3a, 3b 3c, 4a and 4b) and indusium griseum
(Figures 3a, 3b). In the cerebellum, in spite of a strong
staining in the whole mount (Figure 2), only a faint LacZ
signal was observed in sections (Figures 5a, 5b) in partic-
ular in the granule cells, close to the nuclei. The RT-PCR
on cortical and cerebellar extracts confirmed the presence
of LacZ expression in these brain areas (Figure 6).
In subcortical regions, LacZ was detected in the anterior
ventral, mediodorsal, ventrolateral, anteromedial and
central lateral thalamic nuclear groups (Figure 7a). In
more caudal thalamic areas, LacZ was again detectable in
the posterior thalamic nuclear group (Po), and to a lesser
extent in posteromedial, in posterolateral and in reticular
thalamic nuclei and also in the dorsal lateral geniculate
nuclei (Figures 7b, 7c, 7d and 7e). In the tenia tecta, LacZ
staining visible in the whole mount preparation was con-
firmed (Figures 2, 8a, 8b). The RT-PCR on substriatal
regions including the thalamus, the midbrain and the
pontine areas confirmed the presence of LacZ expression
in some of these brain areas (Figure 6). To exclude any
potential impact of LacZ blood signal contamination in
brain areas, RT-PCR on 5 to 20 μl of whole blood was car-
ried out and did not reveal any significant signal [Addi-
tional files 2, 3].
In the hippocampus, LacZ expression was observed in the
cytoplasm of a few pyramidal cells and through the fibers
of the oriens and radiatum layer in a rostral caudal spread
(Figure 9a). In rostral sections, LacZ was expressed in the
septohippocampal nuclei (Figure 8a). In more caudal sec-
tions LacZ was present in the CA1 and CA3, and in a lesser
extent in the CA2 (Figures 9b, 9c and 9d). In the CA3 LacZ
was strongly expressed in the oriens and pyramidal cell
PTPH1-KO adult mouse brain Figure 1
PTPH1-KO adult mouse brain. a: whole brain, dorsal view, staining in cerebellum (Cb) and cortex (Co); b: LacZ staining on 
brain, sagittal view: detection in the tenia tecta (Tt), cortex (Co), thalamus (Th), hippocampus (H), retrosplenial cortex (Rc), 
septum (S) and in the granule cell layer of cerebellum.
Co
Cb
Rc
Co
S
Tt
Th
Cb
H
abBehavioral and Brain Functions 2008, 4:36 http://www.behavioralandbrainfunctions.com/content/4/1/36
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layer (Figure 9d), but its intensity was reduced in the
radiatum and oriens compared to CA1 (Figure 9b). No
staining was detected in the lacunosum-molecular layer in
CA1, CA2 and CA3 (Figures 9b, 9c and 9d). The dentate
gyrus showed a strong positive LacZ signal in the molecu-
lar layer, but not in the hilus (Figure 9e).
Behavioral phenotyping
As previously demonstrated, PTPH1-KO mice were
healthy, reproduced normally and did not show any phe-
notypic traits distinguishing them from their WT litterma-
tes by simple visual observations [22,33]. An increased
body weight has been detected in PTPH1-KO mice com-
pared to WT littermates, more pronounced in male mice
and probably due to an enhanced GHR sensitivity, that
leads to increased IGF-1 mRNA and protein expression in
liver and plasma, respectively [22].
In EPM, open field test and hot plate tests (anxiety-related
behavior and thermal pain sensitivity), PTPH1-KO male
and female mice did not show any significant differences
in comparison with their WT littermates (data not
shown).
Table 2: Qualitative estimation of LacZ staining intensity in the different brain areas.
Brain Area Intensity of LacZ staining Brain Area Intensity of LacZ staining
Cerebral cortex + Dorsal Tenia Tecta ++
Retrosplenial cortex ++ Septohippocampal nu +
CA1 oriens layer +++ VPL +
CA1 radiatum layer +++ MDL ++
CA1 pyramidal cell layer + AV ++
CA2 oriens layer - VPM ++
CA2 radiatum layer - VL +
CA2 pyramidal layer + VM ++
CA3 oriens layer + Po ++
CA3 radiatum layer +/- LD +
CA3 pyramidal layer + Rt +
DG granular cell layer - DLG ++
DG molecular layer +++ VPPC ++
DG hilus - PF -
Fascicola cinereum ++ cerebellum +
Indisium griseum +
-: absent; +/-: faint; +: present; ++: intense; +++: very intense staining. Cornu Ammonis (CA), Dentate Gyrus (DG), mediodorsal lateral (MDL), 
anteroventral (AV), ventromedial (VM) ventral posteromedial (VPM), ventrolateral (VL), ventral posterolateral (VPL), laterodorsal (LD), posterior 
(Po) and reticular (Rt), ventral posteromedial parvicel (VPPC) thalamic nuclei, lateral geniculate nucleus (DLG), parafascicular thalamic nuclei (PF), 
nuclei (nu).
a: PTPH1-KO cerebral cortex (10×, scale bar: 220 μm) Figure 2
a: PTPH1-KO cerebral cortex (10×, scale bar: 220 μm). b: 
positive cytoplasmatic and perinuclear LacZ staining (blue 
dots) in the external pyramidal (III) and internal granular 
layer (IVA) (63×, scale bar: 10 μm).
I
II
III
IVa
a
b
PTPH1-KO cerebral cortex Figure 3
PTPH1-KO cerebral cortex. a: LacZ detection in retrosple-
nial cortex (Rc) and indusium griseum (ig) staining (4×, scale 
bar: 80 μm). b: detail of the Rc and ig (40×, scale bar: 20 μm); 
c: positive cytoplasmatic staining of the neurons of Rc (63× 
scale bar: 10 μm); the interneural LacZ signals are due to the 
presence of trans-sectioned axons and dendrites.
a
c
b
Rc
ig
ig
RcBehavioral and Brain Functions 2008, 4:36 http://www.behavioralandbrainfunctions.com/content/4/1/36
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In the accelerated rotarod and Y-maze test, significant dif-
ferences were observed between PTPH1-KOs and WTs
based on gender and genotype factors. In the accelerating
rotarod test PTPH1-WT mice did not show any gender dif-
ferences (P2WAY = 0.5824 (WT gender vs WT activity); PAUC
= 0.3218 (PTPH1-WT male vs female)) (Figure 10a).
PTPH1-KO male mice displayed an overall significant bet-
ter performance compared to their matched female litter-
mates (P2WAY = 0.007 (KO gender vs KO activity) (Figure
10b). Post-hoc T-test analyses showed that the difference
was significant at the second trial of the test (P0 = 0.109;
P30 = 0.015; P60 = 0.067; P90 = 0.835), and the area under
the curve for PTPH1-KO male mice was significantly
higher (by 50%) compared to the matched values of the
female littermates (P = 0.0194) (Figure 10c).
Considering this gender effect, the follow up analysis was
carried out in males or females assessing genotype effects
on activity. PTPH1-KO female mice performed signifi-
cantly worse compared to their matched WT littermates,
starting from the second trial and onwards (P0 = 0.171; P30
= 0.002; P60 = 0.028; P90 = 0.025) (Figure 10d). No signif-
icant differences were observed in PTPH1-KO male mice
compared to their matched WT littermates (P0 = 0.92; P30
= 0.363; P60 = 0.222; P90 = 0.135) (Figure 10e).
In the Y-maze test, no differences were detected between
PTPH1-KO and WT female mice either in working mem-
ory (Pfemale = 0.972) or in locomotion indices (Pfemale =
0.73; Figures 11a, 11b). On the other hand, PTPH1 KO
male mice displayed a significantly higher working mem-
PTPH1-KO cerebral cortex Figure 4
PTPH1-KO cerebral cortex. a: colocalization of NeuN-ir and LacZ staining signal in the Rc (100×, scale bar: 4.5 μm).; b: detail 
of the cytoplasmatic signal of LacZ in neurons.
a b
PTPH1-KO cerebellar cortex Figure 5
PTPH1-KO cerebellar cortex. a: faint LacZ staining in the granule cell layer (20×, scale bar: 16.5 μm); b: perinuclear staining in 
the granule cell layer of the cerebellum (63×; scale bar: 5 μm).
abBehavioral and Brain Functions 2008, 4:36 http://www.behavioralandbrainfunctions.com/content/4/1/36
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ory index (percentage of exact alteration; Pmale = 0.041)
but similar locomotion activity (total arm entries) (Pmale =
0.348) compared to their matched WT littermates (Figures
11a, 11b).
Discussion
PTPs are key factors in multiple signaling pathways, lead-
ing to modulated functional activities in various cell types
[34,35]. Among all PTP forms, PTPH1 has been shown in
vitro to modulate cardiac sodium channel Nav1.5 [19],
that it is also known to be expressed in the axons of cere-
bral cortex, cerebellum, thalamus and brain stem [36].
Moreover, PTPH1 contains a domain with high sequence
homology with the members of the band 4.1 superfamily
protein, FERM. This domain mediates the linkage of actin
filaments to the plasma membrane [37], and therefore
may be involved in cytoskeleton-membrane interactions,
crucial for axon functionality. To further understand the
potential role of PTPH1 in neural functions in vivo, we first
investigated its expression pattern in embryonic and adult
PTPH1-KO mice CNS by LacZ staining, and second its role
in CNS functions by behavioral phenotype characteriza-
tion.
In rat embryonic stage Es19, PTPH1 expression through
FISH analyses has already been shown in the dorsal tha-
lamic nuclei, which give rise to the thalamo-cortical con-
nections in adulthood [10]. Thus, it has been suggested to
play a role in the maintenance of these connections in
adults. We replicated these data in PTPH1-KO mice at
Es14 and Es16 embryonic stages. PTPH1 is expressed in
the hypothalamic area and but also in the dorsal root gan-
glia of the spinal cord, excluding the spinal cord itself
[Additional file 1] [38]. Moreover, at postnatal P1, PTPH1
expression is also present in peripheral organs such as
muscles and intestines as in the adults [22]. On the other
hand, the CNS expression at P1 appears weaker than in
the adults suggesting a pattern of PTPH1 expression corre-
sponding to specific developmental stages of the CNS as
well as peripheral organs (data not shown). These changes
in expression may play a role in various developmental
functions that need to be further understood.
In PTPH1-KO adults, LacZ is expressed in different CNS
areas such as cerebral and retrosplenial cortices (Figures 1,
2, 3 and 4), hippocampus (Figure 9), thalamus (preferen-
tially ventral thalamus) (Figure 7), cerebellum (Figure 5)
and in the region of the tenia tecta (Figures 1, 8). This data
confirms previously observed expression patterns in the
rat brain by Sahin et al. [10] and extends the observation
to other brain regions. We, furthermore, demonstrate that
PTPH1 is expressed within the cytoplasm and close to the
cell membrane of neurons in most of the brain area inves-
tigated (Figures 4a, 4b). It is known that the FERM
domain is indeed necessary for PTPH1 localization close
to the plasma membrane in Jurkat T cells [14] and it could
be responsible for the punctate expression pattern of
PTPH1 in the cytosol of the neurons (Figure 4b) [39]. This
supports the concept that PTPH1 may be involved in
cytoskeleton-membrane interaction within extended neu-
ronal population in the CNS, potentially playing a role in
various neuronal functions.
Indeed the neural expression of PTPH1 in CA1, CA3 and
DG of the hippocampus (Figures 9a, 9b, 9c, 9d and 9e), in
the retrosplenial cortex (Figures 3, 4) and in a series of tha-
lamic nuclei (Figures 7a, 7b, 7c, 7d and 7e) suggests an
involvement of PTPH1 in the modulation of the memory
circuit. Both hippocampus and retrosplenial cortex are
key regions in the spatial working memory functions [40-
46]. Moreover, several thalamic nuclei have also been
shown to be important in the memory process [47,48].
For example, a strong loss of dorsomedial and ventral pos-
terior thalamic neurons is associated with severe cognitive
and memory disabilities in patients affected by traumatic
brain injury [49]. Lesions in the lateral thalamus may lead
to important working memory defects in rodents [50].
The anterior thalamic nuclei project via the retrosplenial
cortices to the hippocampus [51,52], thus underlying the
importance of both these circuits and of PTPH1 in the
mnemonic process.
Another interesting PTPH1-positive area is the indusium
griseum (Figures 3a, 3b) whose role in the adult brain is
not clear. It is thought to be part of the limbic system,
RT-PCR for beta-galactosidase expression in brain extracts Figure 6
RT-PCR for beta-galactosidase expression in brain extracts. 
Beta-gal mRNA is expressed in PTPH1-KO cerebellum, cor-
tex, hippocampus and substriatal regions (midbrain, thalamic 
nuclei, pontine region); no beta-gal expression detected in 
WT brain extracts (first lane of each block); histone H2A 
gene was used as positive control (second lane).
CEREBELLUM
CORTEX
HIPPOCAMPUS
MIDBRAIN
WT KO
WT KO
WT KO
WT KO
LacZ
H2A
LacZ
H2A
LacZ
H2A
LacZ
H2A
CEREBELLUM
CORTEX
HIPPOCAMPUS
MIDBRAIN
WT KO
WT KO
WT KO
WT KO
LacZ
H2A
LacZ
H2A
LacZ
H2A
LacZ
H2A
SUBSTRIATAL 
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receiving afferents from the entorhinal and pyriform cor-
tex and projecting to the septohippocampal nuclei, olfac-
tory tubercle (presumably the tenia tecta) and the medial
frontal cortex [53,54]. The expression of PTPH1 in these
specific regions suggests a potential role in the processing/
integration of memory and sensory information to the
SHi and likely the cortex.
Indeed PTPH1 expression is also detectable in the pyram-
idal neurons in layer III and IVA of the cerebral cortex of
the mouse (Figures 2a, 2b), in agreement with Sahin's
findings in the rat brain. The middle layers (III and IV) of
the cerebral cortex are key sites for thalamic inputs [55,56]
especially for VPM and VPL, primary thalamic nuclei for
somato-sensory information integration [57]. Further-
more a strong cortico-cortical communication has been
assessed between these two layers [58], thus suggesting a
role for PTPH1 as key regulator in the transmission of the
thalamo-cortical and cortico-cortical information.
The cerebellar cortex is also positive for PTPH1 expres-
sion, in particular in the cytoplasm of granule cells (Figure
5b). The cerebellum is known to be the main structure for
motor learning functions. In particular, the cerebellar cor-
tex seems to be involved in the early learning phases of
motor activities [59,60] that include also a strong activa-
tion of other areas such as prefrontal cortex and basal gan-
glia [29,30]. PTPH1 expression in the granule cells seems
to indicate a potential involvement in the processing of
afferent information to the purkinje cells, since it is
known that afferents fibers to the cerebellar cortex will
project in part through the granule cell layer.
PTPH1 expression pattern observed in our analysis points
out a potential involvement of this phosphatase in
numerous CNS processing functions such as locomotion,
sensorial integration, learning and memory. In this study,
the behavioral phenotyping of the PTPH1-KO mice
allowed us to test these hypotheses in vivo. Indeed, as
PTPH1-KO thalamus [76] Figure 7
PTPH1-KO thalamus [76]. a: LacZ expression detected in several thalamic nuclei (4×; scale bar: 165 μm): mediodorsal (MD), 
central lateral (CL), anteroventral (AV), anteromedial (AM), ventromedial (VM) ventral posteromedial (VPM) and ventrolateral 
(VL) thalamic nuclear groups. MHb: medial habendular nuclei. b: LacZ expression detected in the ventral posteromedial tha-
lamic nuclei (VPM) and it is present also in ventrolateral (VL), ventromedial (VM), ventral posterolateral (VPL), laterodorsal 
(LD), posterior (Po) and reticular (Rt) thalamic nuclei (2.5×, scale bar: 130 μm). c: LacZ is expressed in the dorsal lateral genic-
ulate nucleus (DLG) and in the lateroposteral thalamic nuclear group. In this caudal section LacZ staining is more intense in the 
posterior nucleus, but present also in VPM, VPL and VPPC (ventral posteromedial parvicel) thalamic nuclei (2.5×, scale bar: 13 
μm). d: Detail of beta-gal expression in neural cell body of VPL and VPM at 40× (scale bar: 20 μm) and e: at 63× (scale bar: 10 
μm).
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already demonstrated by our group [22] and also by oth-
ers [33], PTPH1-KO mice are healthy and do not display
any phenotype, distinguishing them from their matched
WT littermates, detectable by simple visual observation.
Therefore PTPH1-WT and KO mice underwent a battery
composed by five behavioral tests, from the least to the
most invasive (Table 1), with the tolerable limitation of
the handling bias.
Behavioral testing revealing locomotor dysfunctions, such
as open-field, EPM and Y-maze did not highlight differ-
ences between the two genotypes (Figure 11b), suggesting
that PTPH1 does not play a critical role in the integration
of locomotor information.
Anxiety-like behaviors measured by open-field (as path in
the center) and EPM (as time spent in the open arms),
exploiting rodents natural aversion to open space, did not
show any differences between the two genotypes (data not
shown), leading to the conclusion that PTPH1 may not be
involved in the integration of thalamo-limbic informa-
tion, key paths for anxiety behavior processing. Similar
conclusions can be drawn from the lack of difference
between the genotypes regarding integration of nocicep-
tive information, based on hot plate test.
In the behavioral test, that partly depends on working
memory performances (Y maze), PTPH1-KO male mice
showed a slightly better short-term memory than their WT
littermates (Figure 11a). Thus, PTPH1 may be involved in
the integration of memory information. This was further
strengthened by results obtained with a test assessing
learning and coordination, the rotarod. Contrary to other
behaviors where little differences have been observed,
learning and coordination capacities in PTPH1-KO
female mice are significantly impaired (Figures 10b, 10c).
The low rotarod performance on the early trials, compen-
sated by the last trial, is suggestive of a delay in learning
acquisition (Figures 10b, 10d).
As reported in Pilecka et al., our PTPH1-KO mice express
the non-catalytic part of PTPH1 in frame with the enzy-
matically active part of LacZ gene. LacZ is widely used as a
reporter for promoter activity in KO mice and all those
mice express a modified protein, whose full function is
not known. So far it was never reported a function of LacZ
alone in cognition and we consider quite unlikely that this
is the case in our mice. Thus, it is very likely that the
behavioral phenotype we detect in our mice is linked to
the deletion of the catalytic domain of PTPH1.
The impairment in learning and coordination of PTPH1-
KO female mice may be resulting from the involvement of
PTPH1 in the GH signaling pathway [21]. Indeed our
group has already shown that PTPH1-KO mice display
higher GHR response in vivo and consequently a higher
expression of its down-stream effector hormone, the IGF1
in liver and plasma [22]. GHR is highly expressed in most
areas of the CNS, in particular in the choroid plexus, hip-
pocampus, putamen, thalamus and hypothalamus. Simi-
larly IGF1 and IGF1-receptors are localized
predominantly in hippocampus, but also in amygdala,
cerebellum and cortex [61]. Although IGF1 is considered
a neuroprotective hormone, it can be produced in the
CNS, it is primarily synthesized in the liver and can cross
the blood-brain barrier [62-65]. The GH-IGF1 axis is also
known to influence cognitive functions due to several
neuroprotective effects on the hippocampus [66]. Further-
more it has been recently pointed out that old conditional
liver-IGF1-KO mice display impaired spatial learning and
memory [67]. The presence of PTPH1 in key CNS regions,
as well as the consequent deregulation of the GH-IGF1
axis in KO mice, strengthens the concept that the PTPH1
network (CNS and downstream peripheral effectors) may
be involved in cognitive functions.
The behavioral tests assessing working memory and spe-
cifically learning revealed not only a genotype effect but
also a gender effect, as mentioned above. Sex hormones
are known to modulate the somatotropic system [68,69].
In humans, testosterone has an important effect on GH
axis, in part by its aromatization to estradiol. Administra-
tion of estrogens, or aromatized androgen, modulates GH
axis neuroregulation [69,70]. In particular, chronic E2
administration has been shown to reduce GH-induced
IGF1 increased expression in liver and plasma via a nega-
tive feedback mechanism, while acute E2 administration
leads to the expected GH-induced IGF1 release [71]. Fur-
thermore, it has been reported that estrogens play not
only regulatory functions on neuroendocrine systems but
PTPH1-KO adult mouse brain Figure 8
PTPH1-KO adult mouse brain. a: beta-gal expression 
detected in the dorsal tenia tecta (Dtt) and in the septohip-
pocampal nuclei (SHi) (4×; scale bar: 165 μm). b: Detail of 
cytoplasmatic LacZ staining in the Dtt and SHi (10×; scale 
bar: 70 μm).
Dtt
Dtt
SHi
SHi abBehavioral and Brain Functions 2008, 4:36 http://www.behavioralandbrainfunctions.com/content/4/1/36
Page 10 of 14
(page number not for citation purposes)
can also have stimulatory or inhibitory impacts on the
inter-connectivity of the hippocampal structure depend-
ing on the gender [72-75], meaning that the same stimu-
lus can have opposite effects in male vs female mice. Thus,
the cognitive behavioral differences observed in our KO
mice are underlying the potential impact of the PTPH1
network on neuroendocrine regulation as well as on cellu-
lar architecture within specific brain regions.
Conclusion
In conclusion, we have demonstrated that PTPH1 is
expressed in neural populations present in adult brain
areas mainly involved in locomotor and cognitive func-
tions. The behavioral assessments have allowed us to
reveal PTPH1 functionality especially within cognitive
domains. Better understanding the interplay between var-
ious phosphatases regulating CNS functions, which now
includes PTPH1, will be key in the future to unravel some
of the complexity of CNS signaling pathways necessary for
information processing.
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displays LacZ-positive staining in the pyramidal cell layer. d: CA3 area shows an intense beta-gal expression in the oriens and 
pyramidal cell layer, and in a less extent in the radiatum (20×). e: The dentate gyrus (DG) displays a strong LacZ staining in the 
molecular layer and not in the hilus (20×) (scale bar: 20 μm). pyr: pyramidal cell layer; oriens: oriens layer; rad: radiatum layer; 
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Rotarod test on PTPH1-WT and KO mice (n = 10) males and females Figure 10
Rotarod test on PTPH1-WT and KO mice (n = 10) males and females. a: WT males and WT females do not display any signif-
icant different performance at the rod (P2WAY = 0.5824) b: KO males and KO females display a significant different perform-
ance (P2WAY = 0.007) (post-hoc T-test: P0 = 0.109; P30 = 0.015; P60 = 0.067; P90 = 0.835). c: 50% difference in the area under the 
curve represented in figure 10a (unpaired T-test, P=0.0194). d: Female KO mice display a worse performance at the rod com-
pared to WT females (P0 = 0.171; P30 = 0.002; P60 = 0.028; P90 = 0.025) e: No significant difference in the performance on the 
rod between male KO and WT mice. a, b, d, e: All the data were analyzed by Two-way Anova followed by T-test; *: p < 0.05; 
**: p < 0.01.
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